For many people living with PMOS (Polyendocrine Metabolic Ovarian Syndrome, formerly known as PCOS), GLP-1 medications may help address one of the underlying drivers of the condition: metabolic dysfunction and insulin resistance.

For years, healthcare providers have known that the name Polycystic Ovary Syndrome (PCOS) doesn't accurately describe the condition.

While weight reduction is certainly one of their most visible effects, the science behind these medications is far more interesting. In my practice, I often discuss GLP-1 therapies not simply as weight loss medications, but as tools that can help improve metabolic health, insulin regulation, inflammation, and overall health outcomes.